Clinical forms of Trypanosoma cruzi infected individuals in the chronic phase of Chagas disease in Puebla, Mexico

Memorias do Instituto Oswaldo Cruz

Volumn 101, Issue 7, 2006, Pages 733-739

  Sánchez Guillén, María Del Carmen ^a   López Colombo, Aurelio ^b   Ordóñez Toquero, Guillermo ^b   Gomez Albino, Isidoro ^b   Ramos Jimenez, Judith ^a   Torres Rasgado, Enrique ^a   Salgado Rosas, Hilda ^a   Romero Díaz, Mónica ^a   Pulido Pérez, Patricia ^a   Pérez Fuentes, Ricardo ^c  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b HOSPITAL DE ESPECIALIDADES   (Mexico)

^c BENEMÉRITA UNIVERSIDAD AUTÓNOMA DE PUEBLA   (Mexico)

Author keywords

Cardiomyopathy; Chagas disease; Clinical forms; Indeterminate form; Seropositive; Trypanosoma cruzi

Indexed keywords

AVES; TRYPANOSOMA CRUZI;

EID: 33751282422     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/s0074-02762006000700005     Document Type: Article

References (40)

1. Acquatella H, Catalioti F, Gomez-Mancebo JR, Davalos V, Villalobos L 1987. Long term control of Chagas disease in Venezuela: effects on serologic findings, electrocardiographic abnormalities, and clinical outcome. Circulation 76: 556-562.
2. Barrera-Pérez MA, Rodríguez-Felix ME, Guzmán- Marín E, Zavala-Velazquez JE 1992. Prevalencia de la enfermedad de Chagas en el estado de Yucatán. Rev Biomed 3: 133-139.
3. Bosseno MF, Barnabé C, Magallón-Gastélum E, Lozano-Kasten F, Ramsey J, Espinoza B, Breniére SF 2002. Predominance of Trypanosoma cruzi lineage I in Mexico. J Clin Microbiol 40: 627-632.
4. Bucio MI, Cabrera M, Segura EL, Zenteno E, Salazar-Schettino M 1999. Identification of immunodominant antigens in Mexican strains of Trypanosoma cruzi. Immunol Invest 28: 257-268.
5. Cortes JM, Velasco CO, Labastida MH, Melchor AH, Duarte N, De-Torre R 1985. La enfermedad de Chagas en Santiago Yosotiche, Oaxaca, Mexico. Salud Publica Mex 27: 60-65.
6. Cruz-Reyes A, Pickering-Lopez JM 2006.Chagas disease in Mexico: an analysis of geographical distribution during the past 76 years - A review. Mem Inst Oswaldo Cruz 101: 345-354.
7. Dias JC 1992. Epidemiology of Chagas disease. In S Wendel, Z Brener, ME Camargo, A Rassi (eds), Chagas Disease (American Trypanosomiasis): Its Impact on Transfusion and Clinical Medicine, International Society of Blood Transfusion, São Paulo, p. 49-80.
8. Dias J, Schofield C 1999. The evolution of Chagas disease (American trypanosomiasis) control after 90 years since Carlos Chagas discovery. Mem Inst Oswaldo Cruz 94 (Suppl. 1): 103-121.
9. Dumonteil E 1999. Update on Chagas. disease in Mexico. Salud Publica Mex 41: 322-327.
10. Ferreira AW, Moraes de Avila SL 1995. Laboratory diagnosis of Chagas heart disease. São Paulo Med J/RPM 113: 767-771
11. Guzman Bracho C, Garcia Garcia L, Floriani Verdugo J, Guerrero Martinez S, Torres Cosme M, Ramirez Melgar C, Velasco Castrejon O 1998. Risk of transmission of Trypanosoma cruzi by blood transfusion in Mexico. Rev Panam Salud Publica 4: 94-99.
12. Hernandez-Becerril N, Mejia AM, Ballinas-Verdugo MA, Garza-Murillo V, Manilla-Toquero E, Lopez R, Trevethan S, Cardenas M, Reyes PA, Hirayama K, Monteon VM 2005. Blood transfusion and iatrogenic risks in Mexico City. Anti-Trypanosoma cruzi seroprevalence in 43,048 blood donors, evaluation of parasitemia, and electrocardiogram findings in seropositive. Mem Inst Oswaldo Cruz 100: 111-116.
13. Huante-Magaña R, Piza-Bernal R, Tabárez-Hernández J, Liera-Romero F, Mata-Carbajal E, Matadamas N 1990. Enfermedad de Chagas en Guerrero. Reporte de dos casos confirmados con xenodiagnósticos. Salud Publica Mex 32: 320-324.
14. Kirchhoff LV, Paredes P, Lomeli-Guerrero A, Paredes-Espinoza M, Ron-Guerrero CS, Delgado-Mejia M, Pena-Munoz JG 2006. Transfusion-associated Chagas disease (American trypanosomiasis) in Mexico: implications for transfusion medicine in the United States. Transfusion 46: 298-304.
15. Luquetti AO, Miles MA, Rassi A, De Rezende JM, De Souza A, Povoa M, Rodriguez L 1986. Trypanosoma cruzi; zymodeme asosociated with acute and chronic Chagas. disease in central Brazil. Trans R Soc Trop Med Hyg 80: 462-470
16. Maguire JH, Mott KE, Of R, Guimaraes A, Franca JT, Almeida de Sousa J, Ramos NB, Sherlock IA 1982. A three-year follow-up study of infection with T. cruzi and electrocardiographic abnormalities in a rural community in northeast Brazil. Am J Trop Med Hyg 31: 42-47.
17. Mendes RP, Hoshino-Shimizu S, Moura da Silva AM, Mota I, Heredia RA, Luquetti AO, Leser PG 1997. Serological diagnosis of Chagas disease: a potential confirmatory assay using preserved protein antigens of Trypanosoma cruzi. J Clin Microbiol 35: 1829-1834.
18. Mazzotti L 1940. Dos casos de enfermedad de Chagas en el estado de Oaxaca. Gac Med Mex 70: 417-420.
19. Mendoza-Gonzalez Jde D, Miranda-Lluck E, Velazco-Castrejon O, Tinoco-Reyna O, Maciel-Pérez Mde J 1995. Chronic Chagas cardiomyopathy. Report of 60 cases. Arch Inst Cardiol Mex 65: 546-550.
20. Moncayo A 1992. Chagas disease: epidemiology and prospects for interruption of transmission in the Americas. World Health Stat Q 45: 276-279.
21. Moncayo A 2003. Chagas disease: current epidemiological trends after the interruption of vectorial and trtansfusional transmission in the Southern Cone countries. Mem Inst Oswaldo Cruz 96: 141-144
22. Monteon VM, Reyes-Lopez PA 1989. Mechanisms of innate and acquired resistance to Trypanosoma cruzi cruzi. Arch Inst Cardiol Mex 59: 529-535.
23. Monteon VM, Reyes-Lopez PA, Sosa-Palacio A, Leon-Tello G, Martinez-Murguia J, Sosa-Jurado F 2005. Heterogeneous distribution of the prevalence of anti-Trypanosoma cruzi antibodies among blood donors in the State of Puebla, Mexico. Salud Publica Mex 47: 116-125.
24. Moraes-Souza H, Bordin JO 1996. Strategies for prevention of transfusion-associated Chagas' disease. Transfus Med Rev 10: 161-170.
25. Oelemann WM, Teixeira MG, Da Costa GV, Borges-Pereira J, De Castro JA, Rodríguez-Coura J, Peralta JM 1998. Evaluation of three comercial enzyme-linked immunosorbent assays for diagnosis of Chagas disease. J Clin Microbiol 36: 2423-2427.
26. OPAS-Organización Panamericana de la Salud 1998. La Salud en las Américas, 569 pp.
27. Perez-Fuentes R, Sanchez-Guillen MC, Gonzalez-Alvarez C, Monteon VM, Reyes PA, Rosales-Encina JL 1998. Humoral nitric oxide levels and antibody immune response of symptomatic and indeterminate Chagas' disease patients to commercial and autochthonous Trypanosoma cruzi antigen. Am J Trop Med Hyg 58: 715-720.
28. Perez-Fuentes R, Guegan J-F, Barnabe C, Lopez-Colombo A, Salgado-Rosas H, Torres-Rasgado E, Briones B, Romero-Diaz M, Ramos-Jimenez J, Sanchez-Guillen MC 2003. Severity of chronic Chagas disease is associated with cytokine/antioxidant imbalance in chronically infected individuals. Int J Parasitol 33: 293-299.
29. Prata A 2001. Clinical and epidemiological aspects of Chagas disease. Lancet Infect Dis 1: 92-100.
30. Ramos-Echevarria AA, Monteon-Padilla VM, Reyes-Lopez PA 1993. Detection of antibodies against Trypanosoma cruzi in blood donors. Salud Publica Mex 35: 56-64.
31. Rangel H, Gatica R, Ramos C 1998. Detection of antibodies against Trypanosoma cruzi in donors from a blood bank in Cuernavaca, Morelos, Mexico. Arch Med Res 29: 79-82.
32. Revollo S, Oury B, Laurent JP, Barnabe C, Quesney V, Carriere V, Noel S, Tibayrenc M 1998. Trypanosoma cruzi: impact of clonal evolution of the parasite on its biological and medical properties. Exp Parasitol 89: 30-39.
33. Sánchez B, Monteón V, Reyes PA, Espinoza B 2001. Standardization of micro-enzyme-linked immunosorbent assay (ELISA) and western blot for detection of Trypanosoma cruzi antibodies using extracts from mexican strains as antigens. Arch Med Res 32: 382-388
34. Sanchez-Guillen MC, Barnabe C, Guegan JF, Tibayrenc M, Velasquez-Rojas M, Martinez-Munguia J, Salgado-Rosas H, Torres-Rasgado E, Rosas-Ramirez MI, Perez-Fuentes R 2002. High prevalence anti-Trypanosoma cruzi antibodies, among blood donors in the State of Puebla, a non-endemic area of Mexico. Mem Inst Oswaldo Cruz 97: 947-952.
35. Storino R, Milei J 1986. Miocardiopatia Chagasica Cronica. Un Enfoque para el Clínico General, Club de Estudio, Buenos Aires, Argentina.
36. Tay J, Schenone H, Sánchez JT, Robert L 1992. Estado actual de los conocimientos sobre la enfermedad de Chagas en la Republica Mexicana. Bol Chil Parasitol 47: 43-53.
37. UNDP/World Bank/WHO 1990. Special Program for Research and Training in Tropical Disease. TDR News, 34.
38. Velasco-Castrejon O, Guzman-Bracho C 1986. Importante of Chagas disease in Mexico. Rev Latinoam Microbiol 28: 275-283.
39. Velasco CO, Valdespino JL, Tapia CRC, Salvatierra C, Guzmán-Bracho C, Magos C, Llausas A, Gutiérrez G, Sepúlveda J 1992. Seroepidemiología de la enfermedad de Chagas en México. Salud Publica Mex 34: 186-196.
40. WHO-World Health Organization 2002. Control of Chagas disease. Second report of the WHO Expert Committee. WHO Tech Rep Ser 905: 59-90.